Pınar, İbrahim E., & Ozkocaman, V. (2023). Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. The European Research Journal, 9(6), 1483-1492. https://doi.org/10.18621/eurj.1359362